Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe e ...

Safety profile established and encouraging efficacy signals demonstrated by reductions in spleen volume and symptom burden scores- Data ...

MaaT Pharma to host a KOL webinar on December 17th, 2024, to discuss data and the unmet medical need in acute Graft-versus-Host Disease (aGvHD) Register here. Sustained High Response Rates at ...